Your browser doesn't support javascript.
loading
Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis.
Koarai, Akira; Yamada, Mitsuhiro; Ichikawa, Tomohiro; Fujino, Naoya; Kawayama, Tomotaka; Sugiura, Hisatoshi.
Affiliation
  • Koarai A; Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan. koarai@rm.med.tohoku.ac.jp.
  • Yamada M; Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
  • Ichikawa T; Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
  • Fujino N; Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
  • Kawayama T; Division of Respirology, Neurology and Rheumatology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.
  • Sugiura H; Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Respir Res ; 22(1): 183, 2021 Jun 22.
Article in En | MEDLINE | ID: mdl-34154582

Full text: 1 Database: MEDLINE Main subject: Muscarinic Antagonists / Adrenergic beta-2 Receptor Agonists Type of study: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Respir Res Year: 2021 Type: Article Affiliation country: Japan

Full text: 1 Database: MEDLINE Main subject: Muscarinic Antagonists / Adrenergic beta-2 Receptor Agonists Type of study: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Respir Res Year: 2021 Type: Article Affiliation country: Japan